Clinical Trial: A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06963177) titled 'A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain' on April 28.

Brief Summary: This study is designed to evaluate the safety and efficacy of GenSci048 for moderate to severe endometriosis-associated pain treatment.

Study Start Date: June 19

Study Type: INTERVENTIONAL

Condition: Endometriosis-related Pain

Intervention: DRUG: GenSci048

Administered SC.

DRUG: Placebo

Administered SC.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT Syndication....